Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study.
Saved in:
| Title: | Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study. |
|---|---|
| Authors: | Fathima P; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. parveen.fathima@sydney.edu.au.; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, WA, Australia. parveen.fathima@sydney.edu.au., Jones M; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, WA, Australia., D'Souza R; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, WA, Australia., Totterdell J; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Andric N; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Abbott P; Department of General Practice, Western Sydney University, Campbelltown, NSW, Australia., Norman R; School of Population Health, Curtin University, Perth, WA, Australia., Howard K; Menzies Centre for Health Policy and Economics, University of Sydney, Sydney, NSW, Australia., Cheng W; Department of Gastroenterology and Hepatology, Royal Perth Hospital, Perth, WA, Australia.; Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia., Pedrana A; Burnet Institute, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Doyle JS; Burnet Institute, Melbourne, VIC, Australia.; Department of Infectious Diseases, Monash University, Clayton, VIC, Australia., Davies J; Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.; Infectious Diseases Department, Royal Darwin Hospital, Darwin, NT, Australia., Snelling T; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Infectious Diseases and Microbiology, The Children's Hospital at Westmead, Sydney, NSW, Australia. |
| Source: | Trials [Trials] 2024 Jun 17; Vol. 25 (1), pp. 387. Date of Electronic Publication: 2024 Jun 17. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1745-6215 |
|---|---|
| DOI: | 10.1186/s13063-024-08212-8 |
